These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12708456)

  • 21. Transnational pharmaceutical corporations and neo-liberal business ethics in India.
    D'Mello B
    J Bus Ethics; 2002 Mar; 36(1-2):165-85. PubMed ID: 12625343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug makers to cut prices for developing countries.
    AIDS Alert; 1998 Aug; 13(8 Suppl):1-2. PubMed ID: 11365655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opportunistic pricing: a new scourge, a new call for action.
    Proj Inf Perspect; 1998 Dec; (26):1-5. PubMed ID: 11366486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Policy watch. Profitable pills.
    Gebbie KM
    AIDS Read; 2004 Mar; 14(3):106, 109. PubMed ID: 15067998
    [No Abstract]   [Full Text] [Related]  

  • 25. [Mechanism and implication of regulation of the pricing of essential medicines in the private pharmaceutical sector in Mali].
    Maïga D; Maïga S; Maïga MD
    Med Trop (Mars); 2010 Apr; 70(2):184-8. PubMed ID: 20486360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beyond government intervention: drug companies and bioethics.
    Dresser R
    Am J Bioeth; 2002; 2(3):42-3. PubMed ID: 12230855
    [No Abstract]   [Full Text] [Related]  

  • 27. Access to AIDS medicine: ethical considerations.
    Swartz O
    Indian J Med Ethics; 2004; 1(3):75-6. PubMed ID: 16370076
    [No Abstract]   [Full Text] [Related]  

  • 28. Selling prescription drugs to the consumer: with Vioxx's withdrawal, new questions on a $3.8 billion ad business.
    Elliott S; Ives N
    N Y Times Web; 2004 Oct; ():C1, C9. PubMed ID: 15487065
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmaceutical companies and global lack of access to medicines: strengthening accountability under the right to health.
    Grover A; Citro B; Mankad M; Lander F
    J Law Med Ethics; 2012; 40(2):234-50. PubMed ID: 22789043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Companies facing ethical issue as drugs are tested overseas.
    Kolata G
    N Y Times Web; 2004 Mar; ():A1, A15. PubMed ID: 15022671
    [No Abstract]   [Full Text] [Related]  

  • 31. Addressing the challenge of high-priced prescription drugs in the era of precision medicine: A systematic review of drug life cycles, therapeutic drug markets and regulatory frameworks.
    Gronde TV; Uyl-de Groot CA; Pieters T
    PLoS One; 2017; 12(8):e0182613. PubMed ID: 28813502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Price discrimination in essential medicines: evidence from International Drug Price Indicator Guide data.
    Hanlon M; Zhang R
    Int Health; 2013 Mar; 5(1):58-63. PubMed ID: 24029847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role and responsibility of industry in research.
    Lasagna L
    Dolentium Hominum; 1987; 4(2nd Yr. 1):56-9. PubMed ID: 11653199
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug prices may be too high despite WTO deal.
    Fleck F
    Bull World Health Organ; 2003; 81(10):774-5. PubMed ID: 14758442
    [No Abstract]   [Full Text] [Related]  

  • 35. An unequal activism for an unequal epidemic?
    Selemogo M
    Dev World Bioeth; 2005 May; 5(2):153-68. PubMed ID: 15842724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ethical issues arising from commercial sponsorship and from relationships with the pharmaceutical industry--report and recommendations of the Ethics Subcommittee of the International Headache Society.
    Steiner TJ
    Cephalalgia; 2008 Sep; 28 Suppl 3():1-25. PubMed ID: 18666973
    [No Abstract]   [Full Text] [Related]  

  • 37. How can states provide affordable pharmaceuticals to the underserved?
    Zara J
    J Health Care Poor Underserved; 2006 Nov; 17(4):808-20. PubMed ID: 17242532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The UK House of Commons report on the influence of the pharmaceutical industry: lessons for equitable access to medicines in Australia.
    Faunce TS; Tomossy GF
    Monash Bioeth Rev; 2005 Apr; 24(2):38-42. PubMed ID: 16208881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug pricing and value in oncology.
    Danzon PM; Taylor E
    Oncologist; 2010; 15 Suppl 1():24-31. PubMed ID: 20237214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. World pharmaceutical developments.
    Bale H
    World Hosp Health Serv; 2002; 38(2):1. PubMed ID: 12402745
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.